![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page1141.jpg)
PROFILE trial 1014
(crizotinib vs chemotherapy)
Crizotinib
Chemotherapy
intracranial progression free survival of pts without BM
Brain metastases in patients with ALK-positive NSCLC
BM - brain metastases
Solomon
et al 2016, J Clin Oncol; 34 (24), 2858-65